Effective June 14, 2019, Mélanie Bourassa Forcier is Vice-Chairperson of the Patented Medicine Prices Review Board (PMPRB)
Professor B... Read More
Events
18
Jun2019
17
Jun2019
New “PROVISIONAL ALGORITHMS” at the Centre of Changes to Cancer Therapy Reviews
Effective July 1, 2019, process and operational changes ... Read More
14
Jun2019
Mark down June 26th, 2019 in your calendars.
It is now widely expected the patented medicines price regulations will be in Canada Gazette Part II (CGII), volume 151 ... Read More
12
Jun2019
On June 6th, 2019, Dr. Eric Hoskins, Chair of the Advisory Council on the Implementation of National Pharmacare, along with ... Read More
24
May2019
CADTH’s Pharmaceutical Review Updates are used to communicate new CDR and pCODR drug review processes updates to the public. PDCI ... Read More
15
May2019
Each month the pCPA issues an update on the previous month’s negotiation activity. In Table 1 below you will find ... Read More
02
May2019
PDCI is very pleased to welcome Julia Shen to the PDCI Team as Associate, Corporate Marketing and Policy Research, effective ... Read More
01
Apr2019
We are very pleased to announce that Helena Koa has joined PDCI as Manager, Market Access, effective today, April 1, ... Read More